Diet Rich in Whole Grains May Reduce Overall, CVD Mortality

This article originally appeared here.
Share this content:
Diet Rich in Whole Grains May Reduce Overall, CVD Mortality
Diet Rich in Whole Grains May Reduce Overall, CVD Mortality

TUESDAY, Jan. 6, 2015 (HealthDay News) -- Each 1-ounce serving of whole grains can reduce a person's overall risk of mortality by 5 percent, and risk of mortality due to cardiovascular disease by 9 percent, according to findings published online Jan. 5 in JAMA Internal Medicine.

"We saw clear evidence that the more whole grain intake, the lower the mortality rate is," study coauthor Qi Sun, M.D., Sc.D., an assistant professor of nutrition at the Harvard School of Public Health in Boston, told HealthDay. "When we looked at risk of death from heart disease, there was an even stronger association."

Sun's team based the findings on data from two long-term health studies dating back to the mid-1980s involving 118,085 nurses and health professionals. In the studies, participants were required to fill out food and diet questionnaires every two to four years, which included questions about their whole grain intake.

Over 26 years, there were 26,920 deaths among the people participating in the two studies, the researchers found. One-third fewer people died among the group that ate the most whole grains per day, compared with those who ate the lowest amount of whole grains. However, eating whole grains did not appear to affect a person's risk of mortality due to cancer, the investigators noted.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »